Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice

Journal of Asthma and Allergy

Volumn 9, Issue , 2016, Pages 1-12

  Price, David ^a,b   Wilson, Andrew M ^c   Chisholm, Alison ^d   Rigazio, Anna ^b   Burden, Anne ^b   Thomas, Michael ^e   King, Christine ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Research in Real Life   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d Respiratory Effectiveness Group   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Exacerbator; Hospitalization; Multiple; Risk

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ANTHROPOMETRY; ANXIETY; ARTICLE; ASTHMA; CLINICAL PRACTICE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DISEASE EXACERBATION; ECZEMA; EOSINOPHIL COUNT; GASTROESOPHAGEAL REFLUX; HOSPITALIZATION; HUMAN; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; RHINITIS; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 84955311711     PISSN: None     EISSN: 11786965     Source Type: Journal    
DOI: 10.2147/JAA.S97973     Document Type: Article

References (26)

1. Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations; standardized endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009; 180: 59-99.
2. Kupczyk M, ten Brinke A, Sterk PJ, et al. Frequent exacerbators-a distinct phenotype of severe asthma. Clin Exp Allergy. 2014; 44: 212-221.
3. Thomson NC, Chaudhuri R. Identification and management of adults with asthma prone to exacerbations: can we do better? BMC Pulm Med. 2008; 8: 27.
4. Dougherty RH, Fahy JV. Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy. 2009; 39: 193-202.
5. Barnes PK, Jonsson B, Klim JB. The costs of asthma. Eur Respir J. 1996; 9: 36-42.
6. GINA. The Global Strategy for Asthma Management and Prevention. [updated May 19, 2015]. Available from: http://www. ginasthma. org/local/uploads/files/GINA_Report_2015_May19. pdf. Accessed August 12, 2015.
7. Griswold S, Nordstrom C, Clark S, et al. Asthma exacerbations in North American adults: who are the "frequent fliers" in the emergency department? Chest. 2005; 127: 1579-1586.
8. Miller MK, Lee JH, Miller DP, et al. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med. 2007; 101: 481-489.
9. ten Brinke A, Sterk PJ, Masclee AA, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J. 2005; 26: 812-818.
10. Koga T, Oshita Y, Kamimura T, et al. Characterization of patients with frequent exacerbation of asthma. Respir Med. 2006; 100: 273-278.
11. Osborne ML, Pedula KL, O'Hollaren M, et al. Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study. Chest. 2007; 132: 1151-1161.
12. Tran TN, Khatry DB, Ke X, et al. High blood eosinophil count is associated with more frequent asthma attacks in asthma patients. Ann Allergy Asthma Immunol. 2014; 113: 19-24.
13. Gibson PG. Inflammatory phenotypes in adult asthma: clinical applications. Clin Respir J. 2009; 3: 198-206.
14. Petsky HL, Kynaston JA, Turner C, et al. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev. 2007; 18: CD005603.
15. Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013; 368: 2455-2466.
16. Malinovschi A, Fonseca JA, Jacinto T, et al. Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects. J Allergy Clin Immunol. 2013; 132: 821-827.
17. Schleich FN, Chevremont A, Paulus V, et al. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. Eur Respir J. 2014; 44: 97-108.
18. Zeiger RS, Schatz M, Li Q, et al. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma. J Allergy Clin Immunol Pract. 2014; 2: 741-750.
19. Price DB, Rigazio A, Campbell JD, et al. Blood eosinophil count and prospective annual asthma disease burden: UK cohort study. Lancet Respir Med. 2015; 3: 849-858. http://dx. doi. org/10. 1016/S2213-2600(15)00367-7.
20. Castro M, Zangrilli J, Wechsler ME, et al. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med. 2015; 3: 355-366.
21. Pavord ID, Bafadhel M. Exhaled nitric oxide and blood eosinophilia: independent markers of preventable risk. J Allergy Clin Immunol. 2013; 132: 828-829.
22. BTS-SIGN. British Guideline on the Management of Asthma. 2008 [updated May 2011]. Available from: http://www. brit-thoracic. org. uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2011/. Accessed March 24, 2013.
23. Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J. 2014; 44: 341-350.
24. Amelink M, de Groot JC, de Nijs SB, et al. Severe adult-onset asthma: a distinct phenotype. J Allergy Clin Immunol. 2013; 132: 336-341.
25. Sims EJ, Price D, Haughney J, et al. Current control and future risk in asthma management. Allergy Asthma Immunol Res. 2011; 3: 217-225.
26. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2003; (1): CD001117.